Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of Jin Medical International Ltd. from 30 Sep 2020 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Jin Medical International Ltd. quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD history and change rate from 30 Sep 2020 to 30 Sep 2025.
  • Jin Medical International Ltd. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 30 Sep 2025 was $7,461,630, a 8.3% decline year-over-year.
Source SEC data
View on sec.gov
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

Jin Medical International Ltd. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $7,461,630 -$674,549 -8.3% 30 Sep 2025 20-F 10 Feb 2026 2025 FY
Q1 2025 $11,131,890 +$2,256,988 +25% 31 Mar 2025 6-K 20 Aug 2025 2025 Q2
Q3 2024 $8,136,179 +$1,206,671 +17% 30 Sep 2024 20-F 10 Feb 2026 2025 FY
Q1 2024 $8,874,902 +$190,714 +2.2% 31 Mar 2024 6-K 20 Aug 2025 2025 Q2
Q3 2023 $6,929,508 +$2,136,876 +45% 30 Sep 2023 20-F 10 Feb 2026 2025 FY
Q1 2023 $8,684,188 +$5,042,133 +138% 31 Mar 2023 6-K 26 Jul 2024 2024 Q2
Q3 2022 $4,792,632 +$1,120,372 +31% 30 Sep 2022 20-F 10 Feb 2026 2025 FY
Q1 2022 $3,642,055 31 Mar 2022 6-K 23 Aug 2023 2023 Q2
Q3 2021 $3,672,260 +$2,008,736 +121% 30 Sep 2021 20-F 24 Jan 2025 2024 FY
Q3 2020 $1,663,524 30 Sep 2020 20-F 26 Apr 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.